Status:
COMPLETED
BedMed-Frail: Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations?
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Alberta Innovates Health Solutions
Canadian Institutes of Health Research (CIHR)
Conditions:
Hypertension
Dementia
Eligibility:
All Genders
Phase:
NA
Brief Summary
High blood pressure (present in 1 of 5 Canadian adults) increases the risk of heart attack and stroke. Blood pressure lowering pills reduce this risk - but perhaps not optimally. A Spanish study sugge...
Detailed Description
The BedMed trial (led out of the University of Alberta and funded by both Alberta Innovates Health Solutions, and the Canadian Institutes for Health Research) is a pragmatic multi-provincial trial int...
Eligibility Criteria
Inclusion
- Hypertension diagnosis as indicated by ≥ 2 such billing diagnoses at any time in the administrative claims data by any provider
- ≥ 1 once daily BP lowering medication
- Resident in a participating long term care facility.
Exclusion
- Personal history of glaucoma or use of glaucoma medications. Glaucoma is an exclusion because nocturnal hypotension (i.e. excessively low blood pressure while sleeping) has been associated with ischemic optic neuropathy in such patients.
- Any patient / family member or treating physician (all of whom will be notified in advance of the LTC facilities participation in this initiative) requesting the patient not participate.
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
776 Patients enrolled
Trial Details
Trial ID
NCT04054648
Start Date
May 25 2020
End Date
February 29 2024
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Alberta Long Term Care Facilities
Edmonton, Alberta, Canada